Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
39 hedge funds and large institutions have $729M invested in Repare Therapeutics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 18 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
3% more capital invested
Capital invested by funds: $709M → $729M (+$19.4M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.77% less ownership
Funds ownership: 65.73% → 64.97% (-0.77%)
19% less funds holding
Funds holding: 48 → 39 (-9)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$29.7M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$8.21M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.07M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$5.34M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$8.53M |
| 2 |
RI
RTW Investments
New York
|
-$6.98M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$5.81M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.65M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.36M |
RPTX Hedge Fund Activity: Q3 2020 in Review
39 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2020, worth a combined $729M — up 2.7% from $709M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of RPTX and 9 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 11 added.
The largest buyer was BVF Inc, adding an estimated $29.7M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $8.53M sold.
- 39 institutional investors held Repare Therapeutics (RPTX) as of Q3 2020, down from 48 in Q2 2020.
- Funds reported $729M of Repare Therapeutics stock for Q3 2020, up 2.7% quarter-over-quarter.
- 9 funds opened new Repare Therapeutics positions in Q3 2020 and 18 closed out, a net change of -9 holders.
- The largest Repare Therapeutics buyer in Q3 2020 was BVF Inc, an estimated $29.7M added.
- The largest Repare Therapeutics seller in Q3 2020 was Rock Springs Capital Management, an estimated $8.53M sold.
Based on aggregated 13F filings for Q3 2020.